Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Lupin Limited NSE India S.E.

Equities

LUPIN

INE326A01037

Market Closed - NSE India S.E.
Other stock markets
 12:43:55 28/06/2024 BST 		5-day change 1st Jan Change
1,621 INR +2.40% Intraday chart for Lupin Limited +3.87% +22.56%
06-28 India plans incentives for diabetes, obesity drug makers in 2026, government official says RE
06-28 Indian Equities Fall on Friday, Dragged Mainly by Banking Stocks MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
India plans incentives for diabetes, obesity drug makers in 2026, government official says
Lupin Loses Appeal Against EU Anti-Trust Fine
Lupin Appoints CEO for Subsidiary Lupin Manufacturing Solutions
Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada
India's pharma export sales to grow faster this year, trade body says
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection
Lupin Limited Announces Board Appointments
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Lupin Limited Board Recommends Dividend for the Year Ended March 31, 2024
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Lupin Limited Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains
Lupin Limited Announces Launch of Mirabegron Extended-Release Tablets, 25 Mg, in the United States, After Having Received an Approval from the United States Food and Drug Administration
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. LUPIN Stock
  5. News Lupin Limited
  6. Other languages